Importantly, disease-free survival analysis of luminal breast cancer patients from TCGA uncovered PBX1 amplification as a potential biomarker with prognostic value, while the family member with prognostic capacity in PCa has been suggested to be PBX3 (54, 55). Here, PBX1 is linked to breast carcinoma.